Accessibility to effective cancer treatments is a goal of Universal Health Coverage; yet, achieving this in the context of escalating costs in a diversity of Asian nations with different socioeconomic development is extremely challenging. Value-based assessments within the context of each health care system, financing infrastructure that will facilitate appropriate prioritization of high-cost medications, transparency in international pricing and reducing out-of-pocket costs through national insurance programs are measures that Asian countries should take toward Universal Health Coverage for cancer care. Encouraging sharing data on pricing through the World Health Organization, sharing expertise in health technology assessments and regulatory approvals, and exploring bulk negotiations would also strengthen the process of price control. For each individual country, rational selection of national cancer formulary, aiming at price reduction and sound procurement strategies for each drug, is important toward ensuring affordable access to quality cancer medications.

获得有效的癌症治疗是全民健康覆盖的目标; 然而，在社会经济发展不同的亚洲国家成本不断上升的背景下实现这一目标极具挑战性。在每个医疗体系中进行基于价值的评估，为基础设施提供资金，以促进对高价药品进行适当的优先排序，通过国际保险计划提高国际价格的透明度并减少自付费用，这是亚洲国家应采取的措施癌症保健的全民健康保险。鼓励共享定价数据通过世界卫生组织，共享卫生技术评估和监管批准方面的专业知识，并探索批量谈判也将加强价格控制的过程。对于每个国家而言，合理选择国家癌症配方，旨在降低每种药物的价格并制定合理的采购策略，对于确保以负担得起的价格获得优质抗癌药物至关重要。